At what age should I start getting a Dual-Energy X-ray Absorptiometry (DEXA) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Start DEXA Scanning for Osteoporosis

DEXA scanning should begin at age 65 for all women and age 70 for all men, with earlier screening only for those with significant risk factors for osteoporosis. 1, 2

Recommended Screening Ages by Population

Women:

  • Age 65 and older: Universal screening recommended 2, 1
  • Under age 65: Screening only with risk factors using a 2-step approach:
    1. First assess fracture risk with clinical risk assessment tools
    2. Then perform DEXA if risk assessment indicates elevated risk 2

Men:

  • Age 70 and older: Universal screening recommended 1
  • Ages 50-69: Screening only with risk factors present 1, 3

Risk Factors That Warrant Earlier Screening

Consider DEXA scanning before the standard ages if any of these risk factors are present:

  • Low body weight (<70 kg) 1
  • Prior fragility fracture (regardless of age or gender) 1
  • Parental history of hip fracture 1
  • Current smoking 1
  • Excessive alcohol consumption 1
  • Long-term glucocorticoid therapy 1, 4
  • Chronic inflammatory conditions 1, 4
  • Premature menopause or estrogen deficiency 1, 4
  • Hypogonadism 1
  • Secondary causes of osteoporosis (e.g., malabsorption) 4
  • HIV infection (considered a risk factor warranting earlier screening) 2

Special Populations

HIV-Infected Individuals:

  • All HIV-infected postmenopausal women and men ≥50 years should undergo DEXA scanning 2
  • If initial results don't warrant treatment, repeat every 2-5 years 2

Cancer Patients:

  • Earlier screening recommended for patients receiving therapies affecting bone health:
    • Aromatase inhibitors for breast cancer
    • Androgen deprivation therapy for prostate cancer 1

Common Pitfalls to Avoid

  1. Underscreening high-risk populations: Research shows that only 57.8% of eligible women aged 65-74 and 42.7% of women ≥75 years receive recommended screening 5

  2. Overscreening low-risk populations: About 45.5% of women aged 50-59 and 58.6% of women aged 60-64 without risk factors receive unnecessary screening 5

  3. Failure to recognize risk factors: Many patients with significant risk factors are not identified for earlier screening

  4. Inappropriate screening intervals: Standard monitoring interval is 2 years, with shorter intervals (1 year) for high-risk patients or those starting therapy 1

  5. Using the wrong diagnostic criteria: Remember the WHO definitions:

    • Normal: T-score > -1.0
    • Osteopenia: T-score between -1.0 and -2.4
    • Osteoporosis: T-score ≤ -2.5 1

By following these evidence-based guidelines, you can ensure appropriate screening while avoiding unnecessary testing, ultimately reducing fracture risk and improving quality of life for patients at risk of osteoporosis.

References

Guideline

Osteoporosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2013

Research

Diagnosis and management of osteoporosis.

The Practitioner, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.